Notice Announcing Applicant Information Webinar for Phase II of the Undiagnosed Diseases Network (RFA-RM-17-019, RFA-RM-17-018, RFA-RM-17-017, RFA-RM-17-016, RFA-RM-17-015)"

Notice Number: NOT-RM-17-038

Key Dates
Release Date: August 23, 2017

Related Announcements
RFA-RM-17-019
RFA-RM-17-018
RFA-RM-17-017
RFA-RM-17-016
RFA-RM-17-015

Issued by
Office of Strategic Coordination (Common Fund)

Purpose

On August 15, 2017 the NIH issued the Funding Opportunity Announcements (FOAs) RFA-RM-17-019 - “Clinical Sites for the Undiagnosed Diseases Network (UDN) Phase II (U01),”  RFA-RM-17-018 - “Coordinating Center for the Undiagnosed Diseases Network (UDN) Phase II (U01),”  RM-17-017 - “Model Organism Screening Center for the Undiagnosed Diseases Network (UDN) Phase II (U54),” RFA-RM-17-016 - "Sequencing Core(s) for the Undiagnosed Diseases Network (UDN) Phase II (U01)”), and RFA-RM-17-015 - " Metabolomics Core for the Undiagnosed Diseases Network (UDN) Phase II (U01)".

To assist potential applicants to the above-referenced FOAs, this Notice provides information on an Applicant Information Webinar to be provided on September 14, 2017.

Applicant Information Webinar

An Applicant Information Webinar will be held Thursday, September 14 from 3 pm to 4:30 pm (Eastern Time) to provide information about the FOAs to prospective applicants. NIH staff will provide an overview of the FOAs and answer questions from prospective applicants. The webinar is open to all prospective applicants, but participation in the webinar is not a prerequisite to applying. Information about how to participate in the webinar will be posted here: https://commonfund.nih.gov/Diseases/grants/webinar. Afterwards, the webinar slides will be posted on the same site along with Frequently Asked Questions.

Applicants are asked to provide questions in advance of the webinar by email to: [email protected]

Inquiries

Please direct all inquiries to:

Anastasia L. Wise, Ph.D.
National Human Genome Research Institute
Telephone: 301-480-3517
Email: [email protected]